| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 1,107,927 | 958,040 | 1,094,005 | 1,295,765 | | Cost of Revenue | 830,631 | 738,704 | 868,727 | 3,247,968 | | | Gross Profit | 277,296 | 219,336 | 225,278 | (1,952,203) | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 37,476 | 38,822 | 52,952 | (2,166,565) | | Non Recurring |
-
|
-
| 620,000 | 135,800 | | Others | 79,547 | 80,449 | 93,245 | 95,885 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 160,273 | 100,065 | (540,919) | (17,323) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 2,922 | 2,435 | 1,719 | 2,090 | | Earnings Before Interest And Taxes | 165,485 | 104,577 | (537,413) | (14,337) | | Interest Expense | 20,945 | 20,758 | 20,997 | 23,765 | | Income Before Tax | 144,540 | 83,819 | (558,410) | (38,102) | | Income Tax Expense | 51,957 | 28,507 | (214,607) | (26,835) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 98,737 | 55,312 | (343,803) | (11,267) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 92,583 | 55,312 | (343,803) | (11,267) | | Preferred Stock And Other Adjustments | (171) | (172) | (171) | (171) | | | Net Income Applicable To Common Shares | $92,412 | $55,140 | ($343,974) | ($11,438) |
|
1.23% Nasdaq 
Income Statement
